Research ArticleArticle
Open Access
Longterm Effect of Delaying Combination Therapy with Tumor Necrosis Factor Inhibitor in Patients with Aggressive Early Rheumatoid Arthritis: 10-year Efficacy and Safety of Adalimumab from the Randomized Controlled PREMIER Trial with Open-label Extension
Edward C. Keystone, Ferdinand C. Breedveld, Désirée van der Heijde, Robert Landewé, Stefan Florentinus, Udayasankar Arulmani, Shufang Liu, Hartmut Kupper and Arthur Kavanaugh
The Journal of Rheumatology January 2014, 41 (1) 5-14; DOI: https://doi.org/10.3899/jrheum.130543
Edward C. Keystone
From the University of Toronto, Toronto, Ontario,
Canada; Leiden University Medical Center, Leiden,
The Netherlands; Academic Medical Center, Amsterdam,
The Netherlands; AbbVie, Rungis,
France; AbbVie Inc., North Chicago, Illinois,
USA; AbbVie Deutschland GmbH and Co KG, Ludwigshafen,
Germany; University of California San Diego, La Jolla, California,
USA.
Ferdinand C. Breedveld
Désirée van der Heijde
Robert Landewé
Stefan Florentinus
Udayasankar Arulmani
Shufang Liu
Hartmut Kupper
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- Lindqvist E,
- Jonsson K,
- Saxne T,
- Eberhardt K
- 4.↵
- 5.↵
- 6.↵
- Emery P,
- Breedveld FC,
- Dougados M,
- Kalden JR,
- Schiff MH,
- Smolen JS
- 7.↵
- Smolen JS,
- Aletaha D,
- Bijlsma JW,
- Breedveld FC,
- Boumpas D,
- Burmester G,
- et al.
- 8.↵
- 9.↵
- van der Heijde D,
- Breedveld FC,
- Kavanaugh A,
- Keystone EC,
- Landewe R,
- Patra K,
- et al.
- 10.↵
- Nam JL,
- Winthrop KL,
- van Vollenhoven RF,
- Pavelka K,
- Valesini G,
- Hensor EM,
- et al.
- 11.↵
- Singh JA,
- Furst DE,
- Bharat A,
- Curtis JR,
- Kavanaugh AF,
- Kremer JM,
- et al.
- 12.↵
- Smolen JS,
- Landewe R,
- Breedveld FC,
- Dougados M,
- Emery P,
- Gaujoux-Viala C,
- et al.
- 13.↵
- Keystone EC,
- Kavanaugh AF,
- Sharp JT,
- Tannenbaum H,
- Hua Y,
- Teoh LS,
- et al.
- 14.↵
- Lipsky PE,
- van der Heijde DM,
- St. Clair EW,
- Furst DE,
- Breedveld FC,
- Kalden JR,
- et al.
- 15.↵
- Klareskog L,
- van der Heijde D,
- de Jager JP,
- Gough A,
- Kalden J,
- Malaise M,
- et al.
- 16.↵
- Breedveld FC,
- Weisman MH,
- Kavanaugh AF,
- Cohen SB,
- Pavelka K,
- van Vollenhoven R,
- et al.
- 17.↵
- 18.↵
- 19.↵
- Smolen JS,
- Kay J,
- Landewe RB,
- Matteson EL,
- Gaylis N,
- Wollenhaupt J,
- et al.
- 20.↵
- 21.↵
- Keystone EC,
- van der Heijde D,
- Kavanaugh A,
- Kupper H,
- Liu S,
- Guerette B,
- et al.
- 22.↵
- Rubbert-Roth A
- 23.↵
- 24.↵
- 25.↵
- Burmester GR,
- Panaccione R,
- Gordon KB,
- McIlraith MJ,
- Lacerda AP
- 26.↵
- Klarenbeek NB,
- van der Kooij SM,
- Guler-Yuksel M,
- van Groenendael JH,
- Han KH,
- Kerstens PJ,
- et al.
- 27.↵
- Emery P,
- Breedveld FC,
- Hall S,
- Durez P,
- Chang DJ,
- Robertson D,
- et al.
In this issue
The Journal of Rheumatology
Vol. 41, Issue 1
1 Jan 2014
Longterm Effect of Delaying Combination Therapy with Tumor Necrosis Factor Inhibitor in Patients with Aggressive Early Rheumatoid Arthritis: 10-year Efficacy and Safety of Adalimumab from the Randomized Controlled PREMIER Trial with Open-label Extension
Edward C. Keystone, Ferdinand C. Breedveld, Désirée van der Heijde, Robert Landewé, Stefan Florentinus, Udayasankar Arulmani, Shufang Liu, Hartmut Kupper, Arthur Kavanaugh
The Journal of Rheumatology Jan 2014, 41 (1) 5-14; DOI: 10.3899/jrheum.130543
Longterm Effect of Delaying Combination Therapy with Tumor Necrosis Factor Inhibitor in Patients with Aggressive Early Rheumatoid Arthritis: 10-year Efficacy and Safety of Adalimumab from the Randomized Controlled PREMIER Trial with Open-label Extension
Edward C. Keystone, Ferdinand C. Breedveld, Désirée van der Heijde, Robert Landewé, Stefan Florentinus, Udayasankar Arulmani, Shufang Liu, Hartmut Kupper, Arthur Kavanaugh
The Journal of Rheumatology Jan 2014, 41 (1) 5-14; DOI: 10.3899/jrheum.130543